{"id":23852,"date":"2013-05-31T12:51:17","date_gmt":"2013-05-31T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23852"},"modified":"2018-04-14T02:08:20","modified_gmt":"2018-04-14T07:08:20","slug":"23852","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/23852\/","title":{"rendered":"Not\u00edcias e notas de sa\u00fade animal de 31 de maio de 2013"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN_5-31-13.pdf\">vers\u00e3o impressa<\/a><\/p>\n<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <br \/>\nNot\u00edcias e notas de sa\u00fade animal de 31 de maio de 2013<br \/>\n<\/strong>Copyright \u00a9 Brakke Consulting, Inc.<br \/>\n&nbsp;<br \/>\nEditor: Lynn Fondon DVM MBA<br \/>\n************************************<br \/>\nNAS NOTICIAS:<br \/>\n&nbsp;<br \/>\n<u>Novidades da Brakke Consulting<br \/>\n<\/u>Mesa Redonda de Sa\u00fade Animal<br \/>\nServi\u00e7os de Planejamento Estrat\u00e9gico<br \/>\n&nbsp;<br \/>\n<u>outras not\u00edcias<br \/>\n<\/u>Biogal galed<br \/>\nButler Schein<br \/>\nceva<br \/>\nintercelular<br \/>\nLumora<br \/>\nFarmac\u00eautica NovaBay<br \/>\nShuanghui International Holdings<br \/>\nSmithfield Foods<br \/>\nValneva<br \/>\nInstrumenta\u00e7\u00e3o veterin\u00e1ria<br \/>\nVirbac<br \/>\nVivalis<br \/>\n&nbsp;<br \/>\n************************************<br \/>\n<strong>BRAKKE CONSULTING, INC.<br \/>\nSERVI\u00c7OS DE PLANEJAMENTO ESTRAT\u00c9GICO<\/strong><br \/>\n&nbsp;<br \/>\nA Brakke Consulting \u00e9 um excelente recurso para o planejamento estrat\u00e9gico da sua empresa. Alguns dos servi\u00e7os que oferecemos incluem:<br \/>\n\u2013 Revis\u00e3o das estimativas de receita e probabilidade de sucesso do seu pipeline de produtos.<br \/>\n\u2013 Revisar o cronograma de v\u00e1rias introdu\u00e7\u00f5es de novos produtos e estimar o impacto de v\u00e1rios cen\u00e1rios.<br \/>\n\u2013 Benchmarking de v\u00e1rias fun\u00e7\u00f5es em rela\u00e7\u00e3o aos concorrentes da empresa nos mercados maiores, o que pode incluir o tamanho da for\u00e7a de vendas, servi\u00e7os t\u00e9cnicos e\/ou gastos com P&amp;D versus vendas.<\/p>\n<p>Por meio do planejamento estrat\u00e9gico, a Brakke Consulting pode ajudar a aumentar a probabilidade de sucesso dos empreendimentos futuros de sua empresa. Contacte-nos para assist\u00eancia profissional em qualquer uma destas \u00e1reas.<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a><br \/>\n&nbsp;<br \/>\n************************************<br \/>\nCOMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<br \/>\n&nbsp;<br \/>\n&gt; A Virbac anunciou um contrato de colabora\u00e7\u00e3o e licen\u00e7a com a NovaBay Pharmaceuticals, Inc. para adquirir direitos mundiais exclusivos para desenvolver o composto propriet\u00e1rio da NovaBay, auriclosene (NVC-422), para os mercados veterin\u00e1rios globais. O exerc\u00edcio de op\u00e7\u00e3o da Virbac segue seu extenso teste de auriclosene para uso veterin\u00e1rio durante o per\u00edodo de op\u00e7\u00e3o de 12 meses. Os compostos Aganocide da NovaBay, liderados pelo auriclosene, s\u00e3o antimicrobianos t\u00f3picos patenteados com um amplo espectro de atividade contra bact\u00e9rias, v\u00edrus e fungos. (Nasdaq. com) <br \/>\n&nbsp;<br \/>\n&gt; A Veterinary Instrumentation anunciou que a Butler Schein Animal Health trar\u00e1 sua linha de instrumentos cir\u00fargicos e dispositivos ortop\u00e9dicos veterin\u00e1rios para o mercado dos Estados Unidos. A Veterinary Instrumentation, sediada no Reino Unido, desenvolve instrumentos e implantes projetados para cirurgia veterin\u00e1ria e odontologia. (Farm\u00e1cia Animal) <br \/>\n&nbsp;<br \/>\n&gt; Vivalis e Intercell anunciaram uma fus\u00e3o para criar uma nova empresa, a Valneva. Valneva se concentrar\u00e1 no desenvolvimento de vacinas e anticorpos. O portf\u00f3lio de produtos da empresa \u00e9 uma mistura de produtos para sa\u00fade humana e animal. A Valneva, com sede na Fran\u00e7a, planeja lan\u00e7ar uma emiss\u00e3o de direitos de cerca de EUR 40 milh\u00f5es ($51,4 milh\u00f5es). Os termos financeiros n\u00e3o foram divulgados. (Farm\u00e1cia Animal) <br \/>\n&nbsp;<br \/>\n&gt; A Lumora anunciou um contrato de licen\u00e7a e desenvolvimento com a Biogal Galed Labs ACS para desenvolver uma s\u00e9rie de testes veterin\u00e1rios. A parceria envolver\u00e1 um pipeline de desenvolvimento de testes come\u00e7ando com leptospirose. (Genengnews. com) <br \/>\n&nbsp;<br \/>\n&gt; A Smithfield Foods concordou com a aquisi\u00e7\u00e3o pela Shuanghui International Holdings, o acionista majorit\u00e1rio com sede em Hong Kong da Henan Shuanghui Investment &amp; Development Co, que \u00e9 a maior empresa de processamento de carne da China. As duas empresas chegaram a um acordo que avalia a Smithfield em aproximadamente $7,1 bilh\u00f5es, incluindo a assun\u00e7\u00e3o da d\u00edvida l\u00edquida da Smithfield. A empresa continuar\u00e1 a operar como Smithfield Foods sob sua atual equipe de gerenciamento, e sua sede permanecer\u00e1 em Smithfield, Virg\u00ednia, nos Estados Unidos. A Smithfield teve vendas totais de $13 bilh\u00f5es em seu \u00faltimo ano fiscal completo. (Farm\u00e1cia Animal) <br \/>\n&nbsp;<br \/>\n&gt; CHINA A Ceva Sante Animale assinou um acordo de coopera\u00e7\u00e3o cient\u00edfica com a Universidade de Guangzhou (South China Agriculture University), especializada em sa\u00fade av\u00edcola. O objetivo imediato \u00e9 avaliar a vacina Vectormune AI da Ceva contra cepas virulentas locais da gripe avi\u00e1ria, mas a empresa pretende que a uni\u00e3o de suas equipes e dos laborat\u00f3rios universit\u00e1rios chineses tamb\u00e9m contribua para o desenvolvimento de novos produtos com os parceiros chineses. (Farm\u00e1cia Animal)<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\nNOT\u00cdCIAS DE SA\u00daDE ANIMAL<br \/>\n&nbsp;<br \/>\n&gt; BRASIL \u2013 EEB A Organiza\u00e7\u00e3o Mundial de Sa\u00fade Animal (OIE) declarou o Brasil livre da encefalopatia espongiforme bovina (EEB). (Farm\u00e1cia Animal)<br \/>\n&nbsp;<br \/>\n&gt; UE \u2013 FIPRONIL A Autoridade Europeia para a Seguran\u00e7a dos Alimentos (EFSA) considerou o ingrediente ativo fipronil um risco para a sa\u00fade das abelhas quando usado como inseticida agr\u00edcola. A EFSA concluiu que o fipronil representa um alto risco agudo para as abelhas quando usado como tratamento de sementes de milho, particularmente devido \u00e0 deriva de poeira, mas menos devido ao n\u00e9ctar e ao p\u00f3len. (Farm\u00e1cia Animal)<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n<strong>BRAKKE CONSULTING, INC.<br \/>\nMESA REDONDA DE CAF\u00c9 DA MANH\u00c3 SA\u00daDE ANIMAL<br \/>\n13 DE JUNHO DE 2013<br \/>\n<\/strong>&nbsp;<br \/>\nJunte-se \u00e0 Brakke Consulting e \u00e0 Stinson Morrison Hecker LLP em Kansas City para a pr\u00f3xima mesa redonda, \u201cComo a mudan\u00e7a de propriedade est\u00e1 moldando a sa\u00fade animal\u201d, na quinta-feira, 13 de junho de 2013. <br \/>\n&nbsp;<br \/>\nSusan Warren, da Brakke Consulting, e o s\u00f3cio da Stinson, Scott Claassen, fornecer\u00e3o uma revis\u00e3o das fus\u00f5es, aquisi\u00e7\u00f5es e consolida\u00e7\u00f5es nos \u00faltimos anos e como essas mudan\u00e7as est\u00e3o impactando a ind\u00fastria e a profiss\u00e3o veterin\u00e1ria.<br \/>\n&nbsp;<br \/>\nPara se inscrever, acesse <a href=\"http:\/\/www.stinson.com\/registeranimalhealthjune2013\/\">http:\/\/www.stinson.com\/registeranimalhealthjune2013\/<\/a>.<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\nPONTO DE VISTA DA BRAKKE CONSULTORIA<\/p>\n<p>Duas das reportagens desta semana s\u00e3o sobre transa\u00e7\u00f5es ou acordos envolvendo empresas chinesas. Tem havido muita discuss\u00e3o e a\u00e7\u00e3o nos \u00faltimos anos em rela\u00e7\u00e3o \u00e0 entrada de empresas chinesas no mercado norte-americano de gen\u00e9ricos para sa\u00fade animal. O que alguns podem ter esquecido \u00e9 o grande interesse que os pa\u00edses em desenvolvimento t\u00eam em fornecer maiores volumes de alimentos de qualidade para sua crescente popula\u00e7\u00e3o. <br \/>\n&nbsp;<br \/>\nA proposta de aquisi\u00e7\u00e3o da Smithfield por uma empresa chinesa nos parece, a curto prazo, uma vit\u00f3ria para a ind\u00fastria de sa\u00fade animal e su\u00edna dos Estados Unidos. Se a aquisi\u00e7\u00e3o for conclu\u00edda, provavelmente haver\u00e1 um aumento no n\u00famero de su\u00ednos nascidos, alimentados e abatidos nos EUA, o que deve resultar em aumento de receita de produtos e servi\u00e7os para a ind\u00fastria su\u00edna. Acreditamos que esta aquisi\u00e7\u00e3o demonstra a for\u00e7a e as capacidades da agricultura de produ\u00e7\u00e3o de alimentos norte-americana. A Am\u00e9rica do Norte tem os gr\u00e3os para ra\u00e7\u00e3o, gen\u00e9tica e tecnologia necess\u00e1rios para ser um importante fornecedor de prote\u00edna animal em todo o mundo. Provavelmente veremos mais transa\u00e7\u00f5es desse tipo no futuro.<\/p>\n<p>Tenha um \u00f3timo fim de semana!!<br \/>\n&nbsp;<br \/>\nRon Brakke<br \/>\n&nbsp;<br \/>\n**********************************<\/p>\n<p>Este boletim eletr\u00f4nico \u00e9 propriedade exclusiva da Brakke Consulting, Inc.<br \/>\nQualquer uso do conte\u00fado deste documento deve ser aprovado e devidamente atribu\u00eddo \u00e0 Brakke Consulting, Inc.<br \/>\nPara obter mais informa\u00e7\u00f5es sobre os servi\u00e7os e estudos sindicados da Brakke Consulting, visite nosso website em <a href=\"https:\/\/brakkeconsulting.com\/pt\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke Consulting, Inc.<br \/>\n12005 Ford Rd., Suite 530<br \/>\nDallas, TX 75234 EUA<\/p>","protected":false},"excerpt":{"rendered":"<p>vers\u00e3o impressa *********************************** Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 31 de maio de 2013 Direitos autorais \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA ************************************ NO NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting Mesa Redonda de Sa\u00fade Animal Servi\u00e7os de Planejamento Estrat\u00e9gico outras not\u00edcias Biogal Galed Butler Schein Ceva Intercell Lumora NovaBay Pharmaceuticals Shuanghui International Holdings Smithfield Foods Valneva Veterinary Instrumentation Virbac Vivalis ****************** ****************** BRAKKE CONSULTING, INC. SERVI\u00c7OS DE PLANEJAMENTO ESTRAT\u00c9GICO A Brakke Consulting \u00e9 um excelente recurso para o planejamento estrat\u00e9gico da sua empresa. Alguns dos servi\u00e7os que oferecemos incluem: \u2013 Revis\u00e3o de estimativas de receita e probabilidade de sucesso do pipeline de seu produto. \u2013 Revisar o cronograma de lan\u00e7amento de v\u00e1rios novos produtos e estimar o impacto de v\u00e1rios cen\u00e1rios. \u2013 Compara\u00e7\u00e3o de diversas fun\u00e7\u00f5es com concorrentes da empresa nos mercados maiores, o que pode incluir tamanho da for\u00e7a de vendas, servi\u00e7os t\u00e9cnicos e\/ou gastos com P&amp;D versus vendas. Atrav\u00e9s do planejamento estrat\u00e9gico, a Brakke Consulting pode ajudar a melhorar a probabilidade de sucesso dos empreendimentos futuros da sua empresa. Contate-nos para assist\u00eancia profissional em qualquer uma dessas \u00e1reas. www.BrakkeConsulting.com ************************************ COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA &gt; Virbac anunciou uma colabora\u00e7\u00e3o e contrato de licen\u00e7a com a NovaBay Pharmaceuticals, Inc. para adquirir direitos mundiais exclusivos para desenvolver o composto propriet\u00e1rio da NovaBay, o auricloseno (NVC-422), para os mercados veterin\u00e1rios globais. O exerc\u00edcio de op\u00e7\u00e3o da Virbac segue seus extensos testes de auricloseno para uso veterin\u00e1rio durante o per\u00edodo de op\u00e7\u00e3o de 12 meses. NovaBay&#039;s<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/23852\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23852","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/23852\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"print version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for May 31, 2013 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news Animal Health Roundtable Strategic Planning services &nbsp; other news Biogal Galed Butler Schein Ceva Intercell Lumora NovaBay Pharmaceuticals Shuanghui International Holdings Smithfield Foods Valneva Veterinary Instrumentation Virbac Vivalis &nbsp; ************************************ BRAKKE CONSULTING, INC. STRATEGIC PLANNING SERVICES &nbsp; Brakke Consulting is an excellent resource for your company&rsquo;s strategic planning. Some of the services we offer include: &#8211; Reviewing revenue estimates and success probability of your product pipeline. &#8211; Reviewing the timing of various new product introductions and estimate the impact of various scenarios. &#8211; Benchmarking various functions against company competitors in the larger markets, which might include sales force size, technical services and\/or R&amp;D spending vs. sales. Through strategic planning, Brakke Consulting can help improve the likelihood of success for your company&rsquo;s future endeavors.&nbsp; Contact us for professional assistance in any of these areas. &nbsp; www.BrakkeConsulting.com &nbsp; ************************************ COMPANY NEWS RELEASES &nbsp; &gt; Virbac announced a collaboration and license agreement with NovaBay Pharmaceuticals, Inc. to acquire exclusive worldwide rights to develop NovaBay&rsquo;s proprietary compound, auriclosene (NVC-422), for global veterinary markets. Virbac&rsquo;s option exercise follows its extensive testing of auriclosene for veterinary uses during the 12-month option period. NovaBay&rsquo;sView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/23852\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2013-05-31T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:08:20+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23852\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23852\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for May 31, 2013\",\"datePublished\":\"2013-05-31T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:08:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23852\/\"},\"wordCount\":987,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23852\/\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/23852\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2013-05-31T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:08:20+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23852\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/zh\/23852\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23852\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for May 31, 2013\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/23852\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"print version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for May 31, 2013 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke Consulting news Animal Health Roundtable Strategic Planning services &nbsp; other news Biogal Galed Butler Schein Ceva Intercell Lumora NovaBay Pharmaceuticals Shuanghui International Holdings Smithfield Foods Valneva Veterinary Instrumentation Virbac Vivalis &nbsp; ************************************ BRAKKE CONSULTING, INC. STRATEGIC PLANNING SERVICES &nbsp; Brakke Consulting is an excellent resource for your company&rsquo;s strategic planning. Some of the services we offer include: &#8211; Reviewing revenue estimates and success probability of your product pipeline. &#8211; Reviewing the timing of various new product introductions and estimate the impact of various scenarios. &#8211; Benchmarking various functions against company competitors in the larger markets, which might include sales force size, technical services and\/or R&amp;D spending vs. sales. Through strategic planning, Brakke Consulting can help improve the likelihood of success for your company&rsquo;s future endeavors.&nbsp; Contact us for professional assistance in any of these areas. &nbsp; www.BrakkeConsulting.com &nbsp; ************************************ COMPANY NEWS RELEASES &nbsp; &gt; Virbac announced a collaboration and license agreement with NovaBay Pharmaceuticals, Inc. to acquire exclusive worldwide rights to develop NovaBay&rsquo;s proprietary compound, auriclosene (NVC-422), for global veterinary markets. Virbac&rsquo;s option exercise follows its extensive testing of auriclosene for veterinary uses during the 12-month option period. NovaBay&rsquo;sView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/23852\/","og_site_name":"Brakke Consulting Website","article_published_time":"2013-05-31T17:51:17+00:00","article_modified_time":"2018-04-14T07:08:20+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Brakke Consulting","Tempo estimado de leitura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/zh\/23852\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/23852\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for May 31, 2013","datePublished":"2013-05-31T17:51:17+00:00","dateModified":"2018-04-14T07:08:20+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/23852\/"},"wordCount":987,"articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/zh\/23852\/","url":"https:\/\/brakkeconsulting.com\/zh\/23852\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2013-05-31T17:51:17+00:00","dateModified":"2018-04-14T07:08:20+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/zh\/23852\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/zh\/23852\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/zh\/23852\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for May 31, 2013"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"Brakke Consultoria","url":"https:\/\/brakkeconsulting.com\/pt\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=23852"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23852\/revisions"}],"predecessor-version":[{"id":25339,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/23852\/revisions\/25339"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=23852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=23852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=23852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}